How to evaluate and predict the epidemiologic impact of antibiotic use in humans: the pharmacoepidemiologic approach.
Guillemot
D
D
INSERM U258, Villejuif, France. guillemot@pasteur.fr
D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D024881:Drug Resistance, Bacterial / Q000235:genetics; D005544:Forecasting; D017408:Guidelines as Topic / Q000592:standards; D006801:Humans; D008962:Models, Theoretical; D017891:Pharmacoepidemiology; D016016:Proportional Hazards Models
D000900:Anti-Bacterial Agents